Delta 9 Cannabis Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0369
- Today's High:
- $0.0409
- Open Price:
- $0.0409
- 52W Low:
- $0.032
- 52W High:
- $0.173
- Prev. Close:
- $0.037
- Volume:
- 5675
Company Statistics
- Market Cap.:
- $6.49 million
- Book Value:
- 0.028
- Revenue TTM:
- $67.65 million
- Operating Margin TTM:
- -27.3%
- Gross Profit TTM:
- $17.32 million
- Profit Margin:
- -38.46%
- Return on Assets TTM:
- -11.88%
- Return on Equity TTM:
- -194.35%
Company Profile
Delta 9 Cannabis Inc had its IPO on under the ticker symbol DLTNF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Delta 9 Cannabis Inc has a staff strength of 202 employees.
Stock update
Shares of Delta 9 Cannabis Inc opened at $0.04 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.04 - $0.04, and closed at $0.04.
This is a +4.05% increase from the previous day's closing price.
A total volume of 5,675 shares were traded at the close of the day’s session.
In the last one week, shares of Delta 9 Cannabis Inc have increased by +10%.
Delta 9 Cannabis Inc's Key Ratios
Delta 9 Cannabis Inc has a market cap of $6.49 million, indicating a price to book ratio of 0.6846 and a price to sales ratio of 0.1342.
In the last 12-months Delta 9 Cannabis Inc’s revenue was $67.65 million with a gross profit of $17.32 million and an EBITDA of $-12308019. The EBITDA ratio measures Delta 9 Cannabis Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Delta 9 Cannabis Inc’s operating margin was -27.3% while its return on assets stood at -11.88% with a return of equity of -194.35%.
In Q1, Delta 9 Cannabis Inc’s quarterly earnings growth was a positive 100% while revenue growth was a positive 35.4%.
Delta 9 Cannabis Inc’s PE and PEG Ratio
- Forward PE
- 29.7619
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.15 per share while it has a forward price to earnings multiple of 29.7619 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Delta 9 Cannabis Inc’s profitability.
Delta 9 Cannabis Inc stock is trading at a EV to sales ratio of 0.8695 and a EV to EBITDA ratio of -6.4714. Its price to sales ratio in the trailing 12-months stood at 0.1342.
Delta 9 Cannabis Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $87.44 million
- Total Liabilities
- $52.81 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $546166
- Dividend Payout Ratio
- 0%
Delta 9 Cannabis Inc ended 2024 with $87.44 million in total assets and $0 in total liabilities. Its intangible assets were valued at $87.44 million while shareholder equity stood at $4.43 million.
Delta 9 Cannabis Inc ended 2024 with $0 in deferred long-term liabilities, $52.81 million in other current liabilities, in common stock, $-57556898.00 in retained earnings and $14.20 million in goodwill. Its cash balance stood at $1.74 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $15.85 million.
Delta 9 Cannabis Inc’s total current assets stands at $26.80 million while long-term investments were $533333.00 and short-term investments were $0. Its net receivables were $2.10 million compared to accounts payable of $2.90 million and inventory worth $21.09 million.
In 2024, Delta 9 Cannabis Inc's operating cash flow was $0 while its capital expenditure stood at $546166.
Comparatively, Delta 9 Cannabis Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.04
- 52-Week High
- $0.173
- 52-Week Low
- $0.032
- Analyst Target Price
- $
Delta 9 Cannabis Inc stock is currently trading at $0.04 per share. It touched a 52-week high of $0.173 and a 52-week low of $0.173. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.04 and 200-day moving average was $0.05 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 3848% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Delta 9 Cannabis Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.